Rallybio (RLYB) Short Interest Ratio & Short Volume → World’s biggest multibillionaire investor is buying THIS by the ton [picture] (From Stansberry Research) (Ad) Free RLYB Stock Alerts $1.65 +0.07 (+4.43%) (As of 04/25/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Rallybio Short Interest DataCurrent Short Volume2,960,000 sharesPrevious Short Volume1,310,000 sharesChange Vs. Previous Month+125.95%Dollar Volume Sold Short$5.42 millionShort Interest Ratio / Days to Cover1.9Last Record DateApril 15, 2024Outstanding Shares37,810,000 sharesFloat Size17,240,000 sharesShort Percent of Float17.17%Today's Trading Volume324,537 sharesAverage Trading Volume1,319,172 sharesToday's Volume Vs. Average25% Short Selling Rallybio ? Sign up to receive the latest short interest report for Rallybio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRLYB Short Interest Over TimeRLYB Days to Cover Over TimeRLYB Percentage of Float Shorted Over Time Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Rallybio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20242,960,000 shares $5.42 million +126.0%17.2%1.9 $1.83 3/31/20241,310,000 shares $2.42 million +2.3%7.6%6.2 $1.85 3/15/20241,280,000 shares $2.07 million +6.7%7.4%5.7 $1.62 2/29/20241,200,000 shares $2.79 million +11.1%7.0%5.2 $2.33 2/15/20241,080,000 shares $2.01 million +43.4%6.3%4.8 $1.86 1/31/2024753,400 shares $1.02 million +1.2%4.4%3.5 $1.35 Get the Latest News and Ratings for RLYB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rallybio and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024744,600 shares $1.42 million +9.9%4.3%5.1 $1.91 12/31/2023677,600 shares $1.62 million -62.6%3.9%5.5 $2.39 12/15/20231,810,000 shares $5.50 million -14.6%10.7%16.8 $3.04 11/30/20232,120,000 shares $4.05 million -0.5%12.6%24.7 $1.91 11/15/20232,130,000 shares $4.97 million +0.5%12.6%34.2 $2.34 10/31/20232,120,000 shares $8.90 million +119.3%12.6%49 $4.20 10/15/2023966,800 shares $3.56 million -4.3%5.7%24.6 $3.68 9/30/20231,010,000 shares $3.40 million +1.0%6.0%24.3 $3.37 9/15/20231,000,000 shares $4.93 million No Change5.9%12.9 $4.93 8/31/20231,000,000 shares $5.32 million -4.8%5.9%11.5 $5.32 8/15/20231,050,000 shares $6.29 million -1.9%6.2%10.5 $5.99 7/31/20231,070,000 shares $6.40 million -5.3%6.4%11 $5.98 7/15/20231,130,000 shares $6.16 million +4.6%6.8%11.9 $5.45 6/30/20231,080,000 shares $6.11 million +41.8%6.8%11.4 $5.66 6/15/2023761,900 shares $5.62 million -18.6%4.8%8.3 $7.37 5/31/2023936,300 shares $6.70 million -0.1%5.8%15.7 $7.16 5/15/2023936,800 shares $5.10 million -0.1%5.8%16.8 $5.44 4/30/2023938,100 shares $5.06 million +1.5%5.8%16.5 $5.39 4/15/2023924,000 shares $3.98 million +1.0%5.7%14.4 $4.31 3/31/2023914,800 shares $5.22 million +3.3%5.9%14 $5.71 3/15/2023885,800 shares $4.43 million +11.4%5.7%13.5 $5.00 2/28/2023795,400 shares $6.26 million +0.5%5.2%9.3 $7.87 2/15/2023791,200 shares $5.44 million +8.3%5.3%9.1 $6.87 1/31/2023730,300 shares $5.07 million +2.5%4.8%6.3 $6.94 1/15/2023712,800 shares $4.40 million -7.1%4.5%6 $6.17 12/30/2022767,600 shares $5.04 million -0.3%4.9%6.6 $6.57 12/15/2022769,800 shares $5.40 million +1.0%4.4%6.5 $7.02 11/30/2022762,400 shares $4.39 million +0.6%5.3%7.6 $5.76 11/15/2022757,600 shares $4.42 million -1.1%5.2%8 $5.84 10/31/2022766,200 shares $7.32 million -0.4%6.1%13.5 $9.56 10/15/2022769,200 shares $6.69 million +1.3%6.1%14.3 $8.70 9/30/2022759,400 shares $10.99 million +19.0%6.1%15.3 $14.47 9/15/2022638,300 shares $8.62 million -5.1%5.1%11.3 $13.51 8/31/2022672,700 shares $7.43 million -1.4%5.4%12.4 $11.05World’s biggest multibillionaire investor is buying THIS by the ton [picture] (Ad)Don't Buy Bullion or Mining Stocks. Do THIS Instead As gold continues to break all-time highs, many folks will run out and buy bullion or mining stocks. That's not the best way to ride this gold bull market higher. Note, this showed a 995% gain the last time we shared this same investment idea.Click here to find out what to do. RLYB Short Interest - Frequently Asked Questions What is Rallybio's current short interest? Short interest is the volume of Rallybio shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 2,960,000 shares of RLYB short. 17.17% of Rallybio's shares are currently sold short. Learn More on Rallybio's current short interest. What is a good short interest ratio for Rallybio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RLYB shares currently have a short interest ratio of 2.0. Learn More on Rallybio's short interest ratio. What is a good short interest percentage for Rallybio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 17.17% of Rallybio's floating shares are currently sold short. Is Rallybio's short interest increasing or decreasing? Rallybio saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 2,960,000 shares, an increase of 126.0% from the previous total of 1,310,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Rallybio's float size? Rallybio currently has issued a total of 37,810,000 shares. Some of Rallybio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Rallybio currently has a public float of 17,240,000 shares. How does Rallybio's short interest compare to its competitors? 17.17% of Rallybio's shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Rallybio: MediciNova, Inc. (0.53%), Landos Biopharma, Inc. (0.03%), Celularity Inc. (3.73%), Anebulo Pharmaceuticals, Inc. (0.22%), Lantern Pharma Inc. (6.33%), Eagle Pharmaceuticals, Inc. (10.32%), Mural Oncology plc (8.08%), Journey Medical Co. (3.54%), Carisma Therapeutics, Inc. (8.53%), Immix Biopharma, Inc. (2.53%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Rallybio stock? Short selling RLYB is an investing strategy that aims to generate trading profit from Rallybio as its price is falling. RLYB shares are trading up $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rallybio? A short squeeze for Rallybio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RLYB, which in turn drives the price of the stock up even further. How often is Rallybio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RLYB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: MNOV Short Interest Data LABP Short Interest Data CELU Short Interest Data ANEB Short Interest Data LTRN Short Interest Data EGRX Short Interest Data MURA Short Interest Data DERM Short Interest Data CARM Short Interest Data IMMX Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RLYB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap ProfitsYour Money is Not SafeAmerican AlternativeJim Cramer’s “The Biggest Drug Ever”Behind the MarketsThe only accurate crypto trading system I know …Weiss Ratings